How to Screen for Non-Adherence to Antihypertensive Therapy
Open accessThe DOI matches its Crossref record; 64 of the 65 references it cites were found in a registry or an index.
Abstract
The quality of assessment of non-adherence to treatment in hypertensive is poor. Within this review, we discuss the different methods used to assess adherence to blood-pressure-lowering medications in hypertension patients. Subjective reports such as physicians' perceptions are inaccurate, and questionnaires completed by patients tend to overreport adherence and show a low diagnostic specificity. Indirect objective methods such as pharmacy database records can be useful, but they are limited by the robustness of the recorded data. Electronic medication monitoring devices are accurate but usually track adherence to only a single medication and can be expensive. Overall, the fundamental issue with indirect objective measures is that they do not fully confirm ingestion of antihypertensive medications. Detection of antihypertensive medications in body fluids using liquid chromatography-tandem mass spectrometry is currently, in our view, the most robust and clinically useful method to assess non-adherence to blood-pressure-lowering treatment. It is particularly helpful in patients presenting with resistant, refractory or uncontrolled hypertension despite the optimal therapy. We recommend using this diagnostic strategy to detect non-adherence alongside a no-blame approach tailoring support to address the perceptions (e.g. beliefs about the illness and treatment) and practicalities (e.g. capability and resources) influencing motivation and ability to adhere.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Poor adherence to antihypertensive treatment correlates with the magnitude of BP elevation and is an indicator of poor prognosis in hypertensive patients. 78-81”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [80]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Objective indirect (ie, review of pharmacy records, pill counting, electronic monitoring devices) and direct (ie, witnessed intake of medications, biochemical detection of medications in urine or blood) are generally preferred over subjective methods to diagnose nonadherence to antihypertensive treatment. 80,85”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [80]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Discipline and Punish: The Birth of the Prison.
Zukin, S., Foucault, M., & Sheridan, A. (1996) · Contemporary Sociology · doi:10.2307/2077073 · Cited by 15,361
Global burden of hypertension: analysis of worldwide data
Kearney, P. M., Whelton, M., Reynolds, K., Muntner, P., Whelton, P. K., & He, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17741-1 · Cited by 8,594 · cited 3×
“A Cochrane review of interventions with a potential to improve non-adherence was published in 2012 [61•]. Only 13 studies related to non-adherence to antihypertensive treatment were of sufficient quality to be included in this review. Of these, four used self-reported measures of non-adherence, five used pill counts a…”
MethodInfluentialKirk, J., MacDonald, A., Lavender, P., Dean, J., & Rubin, G. (2017) · Biomedicine Hub · doi:10.1159/000480347 · Cited by 3,887
Interventions for enhancing medication adherence
Nieuwlaat, R., Wilczynski, N., Navarro, T., Hobson, N., Jeffery, R., Keepanasseril, A., Agoritsas, T., Mistry, N., Iorio, A., Jack, S., et al. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000011.pub4 · Cited by 2,945
Calhoun, D. A., Jones, D., Textor, S., Goff, D. C., Murphy, T. P., Toto, R. D., White, A., Cushman, W. C., White, W., Sica, D., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.189141 · Cited by 2,237
Medication adherence measures: An overview
Lam, W. Y., & Fresco, P. (2015) · BioMed Research International · doi:10.1155/2015/217047 · Cited by 1,308
Horne, R., Chapman, S. C. E., Parham, R., Freemantle, N., Forbes, A., & Cooper, V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080633 · Cited by 1,174
Self-citationKotseva, K., Wood, D., De Bacquer, D., De Backer, G., Rydén, L., Jennings, C., Gyberg, V., Amouyel, P., Bruthans, J., Castro Conde, A., et al. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487315569401 · Cited by 1,006
(2017) · PubMed · Cited by 961
Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences
Chowdhury, R., Khan, H., Heydon, E., Shroufi, A., Fahimi, S., Moore, C., Stricker, B., Mendis, S., Hofman, A., Mant, J., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht295 · Cited by 931
Incidence and Prognosis of Resistant Hypertension in Hypertensive Patients
Daugherty, S. L., Powers, J. D., Magid, D. J., Tavel, H. M., Masoudi, F. A., Margolis, K. L., O'Connor, P. J., Selby, J. V., & Ho, P. M. (2012) · Circulation · doi:10.1161/circulationaha.111.068064 · Cited by 930
Vrijens, B., Vincze, G., Kristanto, P., Urquhart, J., & Burnier, M. (2008) · BMJ · doi:10.1136/bmj.39553.670231.25 · Cited by 863
de la Sierra, A., Segura, J., Banegas, J. R., Gorostidi, M., de la Cruz, J. J., Armario, P., Oliveras, A., & Ruilope, L. M. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.168948 · Cited by 809
Clarke's Analysis of Drugs and Poisons
Ishii, A. (2004) · Legal Medicine · doi:10.1016/j.legalmed.2004.03.003 · Cited by 772
Good and poor adherence: optimal cut-point for adherence measures using administrative claims data.
Karve, S., Cleves, M. A., Helm, M., Hudson, T. J., West, D. S., & Martin, B. C. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990903126833 · Cited by 620
LC-MS/MS in the Clinical Laboratory - Where to From Here?
Grebe, S. K. G., & Singh, R. J. (2011) · Europe PMC (PubMed Central) · Cited by 574
Choo, P. W., Rand, C. S., Inui, T. S., Lee, M.-L. T., Cain, E., Cordeiro-Breault, M., Canning, C., & Platt, R. (1999) · Medical Care · doi:10.1097/00005650-199909000-00002 · Cited by 546
Resistant hypertension? Assessment of adherence by toxicological urine analysis
Jung, O., Gechter, J. L., Wunder, C., Paulke, A., Bartel, C., Geiger, H., & Toennes, S. W. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e32835e2286 · Cited by 474
Medication adherence: a call for action
Bosworth, H. B., Granger, B. B., Mendys, P., Brindis, R., Burkholder, R., Czajkowski, S. M., Daniel, J. G., Ekman, I., Ho, M., Johnson, M., et al. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.06.007 · Cited by 448
Nguyen, T.-M.-U., Caze, A. L., & Cottrell, N. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12194 · Cited by 417
Tomaszewski, M., White, C., Patel, P., Masca, N., Damani, R., Hepworth, J., Samani, N. J., Gupta, P., Madira, W., Stanley, A., et al. (2014) · Heart · doi:10.1136/heartjnl-2013-305063 · Cited by 404
Self-citationChan, K. S., Fowles, J. B., & Weiner, J. P. (2010) · Medical Care Research and Review · doi:10.1177/1077558709359007 · Cited by 365
Medication Adherence and Persistence as the Cornerstone of Effective Antihypertensive Therapy
BURNIER, M. (2006) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2006.04.006 · Cited by 358
Apparent and true resistant hypertension: definition, prevalence and outcomes
Judd, E., & Calhoun, D. A. (2014) · Journal of Human Hypertension · doi:10.1038/jhh.2013.140 · Cited by 277
Hope, C. J., Wu, J., Tu, W., Young, J., & Murray, M. D. (2004) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/61.19.2043 · Cited by 270
Non-adherence to cardiovascular medications
Kolandaivelu, K., Leiden, B. B., O'Gara, P. T., & Bhatt, D. L. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu364 · Cited by 242
Corrao, G., Zambon, A., Parodi, A., Poluzzi, E., Baldi, I., Merlino, L., Cesana, G., & Mancia, G. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282f4edd7 · Cited by 236
Refractory Hypertension: Definition, Prevalence, and Patient Characteristics
Acelajado, M. C., Pisoni, R., Dudenbostel, T., Dell’Italia, L. J., Cartmill, F., Zhang, B., Cofield, S. S., Oparil, S., & Calhoun, D. A. (2012) · The Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2011.00556.x · Cited by 198
A Proposal for Quality Standards for Measuring Medication Adherence in Research
Williams, A. B., Amico, K. R., Bova, C., & Womack, J. A. (2013) · AIDS and Behavior · doi:10.1007/s10461-012-0172-7 · Cited by 198
Electronic Medication Packaging Devices and Medication Adherence: A Systematic Review
Checchi, K. D., Huybrechts, K. F., Avorn, J., & Kesselheim, A. S. (2014) · JAMA · doi:10.1001/jama.2014.10059 · Cited by 197
El Alili, M., Vrijens, B., Demonceau, J., Evers, S. M., & Hiligsmann, M. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12942 · Cited by 195
Berra, E., Azizi, M., Capron, A., Høieggen, A., Rabbia, F., Kjeldsen, S. E., Staessen, J. A., Wallemacq, P., & Persu, A. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07464 · Cited by 195
Calhoun, D. A., Booth, J. N., Oparil, S., Irvin, M. R., Shimbo, D., Lackland, D. T., Howard, G., Safford, M. M., & Muntner, P. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.02026 · Cited by 185
Therapeutic Drug Monitoring Facilitates Blood Pressure Control in Resistant Hypertension
Brinker, S., Pandey, A., Ayers, C., Price, A., Raheja, P., Arbique, D., Das, S. R., Halm, E. A., Kaplan, N. M., & Vongpatanasin, W. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.067 · Cited by 184
Ceral, J., Habrdova, V., Vorisek, V., Bima, M., Pelouch, R., & Solar, M. (2011) · Hypertension Research · doi:10.1038/hr.2010.183 · Cited by 170
Štrauch, B., Petrák, O., Zelinka, T., Rosa, J., Šomlóová, Z., Indra, T., Chytil, L., Marešová, V., Kurcová, I., Holaj, R., et al. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283652c61 · Cited by 163
Feasibility of an Ingestible Sensor-Based System for Monitoring Adherence to Tuberculosis Therapy
Belknap, R., Weis, S., Brookens, A., Au-Yeung, K. Y., Moon, G., DiCarlo, L., & Reves, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053373 · Cited by 160
Azizi, M., Pereira, H., Hamdidouche, I., Gosse, P., Monge, M., Bobrie, G., Delsart, P., Mounier-Véhier, C., Courand, P.-Y., Lantelme, P., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.022922 · Cited by 152
Dudenbostel, T., Acelajado, M. C., Pisoni, R., Li, P., Oparil, S., & Calhoun, D. A. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.05449 · Cited by 135
Antihypertensive Medication Adherence, Ambulatory Visits, and Risk of Stroke and Death
Bailey, J. E., Wan, J. Y., Tang, J., Ghani, M. A., & Cushman, W. C. (2010) · Journal of General Internal Medicine · doi:10.1007/s11606-009-1240-1 · Cited by 128
From compliance to concordance in diabetes
Chatterjee, J. S. (2006) · Journal of Medical Ethics · doi:10.1136/jme.2005.012138 · Cited by 127
Degli Esposti, L. (2011) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s15619 · Cited by 119
Meddings, J., Kerr, E. A., Heisler, M., & Hofer, T. P. (2012) · BMC Health Services Research · doi:10.1186/1472-6963-12-270 · Cited by 117
Nelson, M. R., Reid, C. M., Ryan, P., Willson, K., & Yelland, L. (2006) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2006.tb00662.x · Cited by 108
Elliott, W. J. (2009) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2009.00138.x · Cited by 101
Proposal of Standardization to Assess Adherence With Medication Records: Methodology Matters
Arnet, I., Kooij, M. J., Messerli, M., Hersberger, K. E., Heerdink, E. R., & Bouvy, M. L. (2016) · Annals of Pharmacotherapy · doi:10.1177/1060028016634106 · Cited by 100
Monitoring compliance in resistant hypertension: an important step in patient management
Burnier, M., Santschi, V., Favrat, B., & Brunner, H. R. (2003) · Journal of Hypertension · doi:10.1097/00004872-200305002-00007 · Cited by 91
Hameed, M. A., Tebbit, L., Jacques, N., Thomas, M., & Dasgupta, I. (2015) · Journal of Human Hypertension · doi:10.1038/jhh.2015.38 · Cited by 89
Ewen, S., Meyer, M. R., Cremers, B., Laufs, U., Helfer, A. G., Linz, D., Kindermann, I., Ukena, C., Burnier, M., Wagenpfeil, S., et al. (2015) · Clinical Research in Cardiology · doi:10.1007/s00392-015-0905-5 · Cited by 88
Wu, P.-H., Yang, C.-Y., Yao, Z.-L., Lin, W.-Z., Wu, L.-W., & Chang, C.-C. (2010) · American Journal of Hypertension · doi:10.1038/ajh.2009.210 · Cited by 84
Fitzgerald, R. L., Rivera, J. D., & Herold, D. A. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.8.1224 · Cited by 79
How do providers assess antihypertensive medication adherence in medical encounters?
Bokhour, B. G., Berlowitz, D. R., Long, J. A., & Kressin, N. R. (2006) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2006.00397.x · Cited by 77
Krousel-Wood, M., Holt, E., Joyce, C., Ruiz, R., Dornelles, A., Webber, L. S., Morisky, D. E., Frohlich, E. D., Re, R. N., He, J., et al. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000382 · Cited by 77
Refractory Hypertension: A Novel Phenotype of Antihypertensive Treatment Failure
Dudenbostel, T., Siddiqui, M., Oparil, S., & Calhoun, D. A. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.06587 · Cited by 77
Schmieder, R. E., Ott, C., Schmid, A., Friedrich, S., Kistner, I., Ditting, T., Veelken, R., Uder, M., & Toennes, S. W. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002343 · Cited by 69
Patel, P., Gupta, P. K. C., White, C. M. J., Stanley, A. G., Williams, B., & Tomaszewski, M. (2016) · Journal of Human Hypertension · doi:10.1038/jhh.2015.103 · Cited by 53
Self-citationLawson, A. J., Shipman, K. E., George, S., & Dasgupta, I. (2015) · Journal of Analytical Toxicology · doi:10.1093/jat/bkv102 · Cited by 50
Potential cost-effectiveness of therapeutic drug monitoring in patients with resistant hypertension
Chung, O., Vongpatanasin, W., Bonaventura, K., Lotan, Y., Sohns, C., Haverkamp, W., & Dorenkamp, M. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000346 · Cited by 46
Paterson, M., Kinnear, M., Bond, C., & McKinstry, B. (2017) · International Journal of Pharmacy Practice · doi:10.1111/ijpp.12242 · Cited by 43
Clyne, W., Mshelia, C., McLachlan, S., Jones, P., Geest, S. D., Ruppar, T. M., Siebens, K., Dobbels, F., & Kardas, P. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-009610 · Cited by 40
Electronic Monitoring of Adherence, Treatment of Hypertension, and Blood Pressure Control
Onzenoort, H. A. W. V., Verberk, W. J., Kroon, A. A., Kessels, A. G. H., Neef, C., van der Kuy, P.-H. M., & Leeuw, P. W. D. (2012) · American Journal of Hypertension · doi:10.1038/ajh.2011.153 · Cited by 32
Hurtado‐de‐Mendoza, A., Cabling, M. L., & Sheppard, V. B. (2015) · Nursing Inquiry · doi:10.1111/nin.12101 · Cited by 24
Kockaya, G., & Wertheimer, A. I. (2010) · Journal of Pharmacy Practice · doi:10.1177/0897190010389336 · Cited by 20
Mathes, J., Kostev, K., Gabriel, A. P., Pirk, O., & Schmieder, R. E. (2010) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp48173 · Cited by 12
Cited by
2018 ESC/ESH Guidelines for the management of arterial hypertension
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy339 · Cited by 10,286
Self-citation2020 International Society of Hypertension Global Hypertension Practice Guidelines
Unger, T., Borghi, C., Charchar, F., Khan, N. A., Poulter, N. R., Prabhakaran, D., Ramirez, A., Schlaich, M., Stergiou, G. S., Tomaszewski, M., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15026 · Cited by 4,132
“witnessed intake of medications, biochemical detection of medications in urine or blood) are generally preferred over subjective methods to diagnose nonadherence to antihypertensive treatment [80,85].”
Self-citationMancia, G., Kreutz, R., Brunström, M., Burnier, M., Grassi, G., Januszewicz, A., Muiesan, M. L., Tsioufis, K., Agabiti-Rosei, E., Algharably, E. A. E., et al. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003480 · Cited by 3,473
Self-citationWilliams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001940 · Cited by 2,885
Self-citation2020 International Society of Hypertension global hypertension practice guidelines
Unger, T., Borghi, C., Charchar, F., Khan, N. A., Poulter, N. R., Prabhakaran, D., Ramirez, A., Schlaich, M., Stergiou, G. S., Tomaszewski, M., et al. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002453 · Cited by 1,283
“• Objective indirect (ie, review of pharmacy records, pill counting, electronic monitoring devices) and direct (ie, witnessed intake of medications, biochemical detection of medications in urine or blood) are generally preferred over subjective methods to diagnose nonadherence to antihypertensive treatment.(80,85) • T…”
Self-citation
Metadata
- Authors
- Gupta, P., Patel, P., Horne, R., Buchanan, H., Williams, B., & Tomaszewski, M.
- Affiliations
- University of Leicester (GB)
- UCL School of Pharmacy (GB)
- University of Nottingham (GB)
- National Institute for Health and Care Research (GB)
- Manchester Academic Health Science Centre (GB)
- Corresponding author
- Tomaszewski, Maciej
- Venue
- Current Hypertension Reports
- Published
- 2016-11-26
- Volume
- 18
- Issue
- 12
- Pages
- 89-89
- ISSN
- 1522-6417 (ISSN-L)
- 1534-3111
- PMC
- PMC5124437
- OpenAlex
- W2554817370
- Cited by
- 84
- References
- 65
- Citations by year
- 2026: 6 · 2025: 4 · 2024: 7 · 2023: 4 · 2022: 6 · 2021: 13 · 2020: 14 · 2019: 10 · 2018: 11 · 2017: 8
- FWCI
- 1.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Current Hypertension Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Repository@Nottingham (University of Nottingham) (publishedVersion, cc-by)
- Repository@Nottingham (University of Nottingham) (submittedVersion, cc-by)
- Nottingham ePrints (University of Nottingham) (submittedVersion, cc-by)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Leicester Research Archive (University of Leicester) (submittedVersion, cc-by)
- Research Explorer (The University of Manchester) (submittedVersion, cc-by)
- Funders
- University of Manchester
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Health Professions › Pharmacy › Pharmacy and Medical Practices
- Keywords
- medication non-adherence, antihypertensive therapy, hypertension, adherence screening, pharmacy records, physician perceptions, liquid chromatography-tandem mass spectrometry, resistant hypertension, patient beliefs about illness
- MeSH terms
- Antihypertensive Agents, Humans, Hypertension, Surveys and Questionnaires, Databases, Factual, Medication Adherence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.